DNL126
- Generic Name
- DNL126
Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Denali Therapeutics Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT06181136
- Locations
- 🇺🇸
University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, United States
🇺🇸UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
🇺🇸University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath